Praxis Precision Medicines target price raised to $725 from $700 by J.P. Morgan
PRAX•J.P. Morgan raised its target price for Praxis Precision Medicines to $725 from $700.
Related News

Anthropic's Australian data centre overwhelmingly opposed by residents
ANT•

Ideaya Biosciences: JP Morgan cuts target price to $55 from $62
IDYA•

Praxis Precision Medicines initiated with buy rating and $713 price target
PRAX•

Boston Scientific announces pricing of $3.0 billion and €4.25 billion senior note offerings
BSX•

Grove Collaborative director Jason H. Karp acquires $6,729.2462 in common shares
GROV•